Riccardi, Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.242
EU - Europa 2.779
AS - Asia 2.525
SA - Sud America 413
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 9.029
Nazione #
US - Stati Uniti d'America 3.141
SG - Singapore 1.153
DE - Germania 1.081
CN - Cina 590
IT - Italia 376
SE - Svezia 372
BR - Brasile 331
VN - Vietnam 243
FR - Francia 206
GB - Regno Unito 151
UA - Ucraina 128
IE - Irlanda 106
FI - Finlandia 94
IN - India 79
RU - Federazione Russa 75
JP - Giappone 66
ID - Indonesia 64
TR - Turchia 58
BD - Bangladesh 57
CA - Canada 56
HK - Hong Kong 52
PL - Polonia 34
NL - Olanda 31
AR - Argentina 30
MX - Messico 25
IQ - Iraq 24
KR - Corea 20
ES - Italia 18
BE - Belgio 16
EC - Ecuador 15
SA - Arabia Saudita 15
AT - Austria 14
CZ - Repubblica Ceca 13
PH - Filippine 13
ZA - Sudafrica 13
IR - Iran 12
LT - Lituania 12
VE - Venezuela 12
CI - Costa d'Avorio 11
PK - Pakistan 10
TW - Taiwan 10
PE - Perù 9
MA - Marocco 8
RO - Romania 8
AU - Australia 7
CH - Svizzera 7
EU - Europa 7
IL - Israele 7
KE - Kenya 7
EG - Egitto 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
CL - Cile 5
KG - Kirghizistan 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
HN - Honduras 4
HR - Croazia 4
JO - Giordania 4
PA - Panama 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
CO - Colombia 3
CY - Cipro 3
JM - Giamaica 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
PT - Portogallo 3
TH - Thailandia 3
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
LB - Libano 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NO - Norvegia 2
PY - Paraguay 2
QA - Qatar 2
TN - Tunisia 2
A1 - Anonimo 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
CG - Congo 1
CR - Costa Rica 1
EE - Estonia 1
KH - Cambogia 1
KM - Comore 1
KW - Kuwait 1
LK - Sri Lanka 1
Totale 9.025
Città #
Singapore 672
Chandler 355
San Jose 324
Ashburn 306
Dallas 254
New York 164
Dublin 104
Los Angeles 95
Beijing 91
Hefei 83
Rome 80
Milan 77
Ho Chi Minh City 74
Munich 70
Nürnberg 68
Jacksonville 67
San Mateo 62
The Dalles 62
Tokyo 62
Hanoi 61
Lauterbourg 60
Jakarta 58
Ann Arbor 48
Helsinki 47
Hong Kong 44
Nanjing 44
Boston 43
Frankfurt am Main 40
Marseille 39
Council Bluffs 37
Bremen 36
Zhengzhou 36
Moscow 35
Izmir 31
São Paulo 31
Wilmington 31
Boardman 30
Princeton 29
St Louis 29
Buffalo 28
Cattolica 27
Chicago 27
Dearborn 27
Kent 27
Warsaw 25
Turku 21
London 20
Seoul 20
Toronto 20
Nanchang 19
Brooklyn 17
Paris 17
Tianjin 17
Brussels 16
Woodbridge 16
Orem 15
Seattle 15
Düsseldorf 14
Kunming 14
Nuremberg 14
Redwood City 14
Santa Clara 14
Denver 13
Hebei 13
Shanghai 13
Da Nang 12
Lancaster 12
Montreal 12
Phoenix 12
Shenyang 12
Tukwila 12
Abidjan 11
Amsterdam 11
Leawood 11
Mexico City 11
Stockholm 11
Atlanta 10
Augusta 10
Baghdad 10
Poplar 10
Pune 10
Ankara 9
Chennai 9
Lawrence 9
Manchester 9
Fairfield 8
Florence 8
Hải Dương 8
Jinan 8
Mountain View 8
Rio de Janeiro 8
Taipei 8
Belo Horizonte 7
Cambridge 7
Changsha 7
Dhaka 7
Houston 7
Jiaxing 7
Johannesburg 7
Las Vegas 7
Totale 4.687
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 456
A phase II study of sunitinib in advanced hepatocellular carcinoma 275
HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection 237
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 236
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm 203
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 199
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis 190
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 190
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 190
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 189
Liver transplantation in patients with alcoholic liver disease: A retrospective study 189
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study 180
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 179
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 176
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 176
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 174
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 171
Non Alcoholic Fatty Liver Disease is Associated with Increased GHBP and Reduced GH/IGF-I Levels 170
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 155
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 155
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 150
Correlation Between QElaXto Techniques and Supersonic Imagine for Liver Stiffness Quantification in Chronic Liver Disease 150
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 148
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 148
Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes. 147
Dynamic Contrast-Enhanced Ultrasound in the Prediction of Advanced Hepatocellular Carcinoma Response to Systemic and Locoregional Therapies 145
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 142
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 136
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 135
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 133
Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment 133
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 132
The role of elastography in non-Alcoholic fatty liver disease 127
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 126
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 122
Correlation between a New Point-Shear Wave Elastography Device (X+pSWE) with Liver Histology and 2D-SWE (SSI) for Liver Stiffness Quantification in Chronic Liver Disease 121
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 117
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 116
Diffuse liver infiltration by lobular breast carcinoma: Shear wave elastography as gold standard imaging study. 115
The Gemelli Ultrasound Chronic Pancreatitis Score: A Non-invasive Tool for the Diagnosis of Chronic Pancreatitis 113
Minimal Hepatic Encephalopathy is Associated with Increased Cerebral Vascular Resistance. A Transcranial Doppler Ultrasound Study 113
Prognostic value of liver stiffness in patients hospitalized for acute decompensated heart failure: a meta-analysis 110
Clinical impact of comorbidities in an Italian NAFLD cohort 109
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 108
Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma 108
Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients undergoing anti-TNFα therapy 108
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study 106
Elastography assessment in patients with chronic HCV infection 104
Contrast-Enhanced Imaging in the Management of Intrahepatic Cholangiocarcinoma: State of Art and Future Perspectives 103
A new ultrasound score for the assessment and follow-up of chronic pancreatitis: The ‘Gemelli USCP score’ 101
The Role of Transabdominal Ultrasound Elastography in Gastrointestinal Non-Liver Diseases: Current Application and Future Prospectives 100
Assessing Baveno VI criteria with liver stiffness measured using a new point-shear wave elastography technique (BAVElastPQ study) 100
COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT 93
Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 88
Shear Wave Dispersion in Chronic Liver Disease: From Physical Principles to Clinical Usefulness 88
Treatment of Portal Vein Tumor Thrombosis (PVTT) Can Impact Survival of Patients With Advanced HCC? 88
New Therapeutic Perspectives for Management of Advanced Hepatocellular Carcinoma With Hepatic Arteriovenous Fistula: Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial Chemoembolization (TACE) 88
Hepatocellular carcinomas <2 cm in diameter complicating cirrhosis: ultrasound and clinical features in 153 consecutive patients 86
Effectiveness of Radiofrequency Ablation of Hepatocellular Carcinoma 85
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate 85
Single-Step Balloon-Occluded Percutaneous Radio-Frequency Thermal Ablation (RFA) Plus Transcatheter Arterial Chemoembolization (TACE) for Treatment of "Complex" Unresectable Hepatocellular Carcinoma 84
Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab 82
Dynamic contrast enhanced ultrasound in gastrointestinal diseases: A current trend or an indispensable tool? 72
bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial 61
Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric Surgery 55
Evolution of focal nodular hyperplasia during long-term ultrasound follow-up: results from a single-center study 34
Liver Elastography for Liver Fibrosis Stratification: A Comparison of Three Techniques in a Biopsy-Controlled MASLD Cohort 18
Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis, and inflammation in metabolic dysfunction-associated steatotic liver disease 1
Totale 9.124
Categoria #
all - tutte 34.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022411 20 27 13 25 31 8 10 69 14 37 64 93
2022/20231.110 140 133 85 184 55 112 71 95 122 28 49 36
2023/2024645 23 141 33 31 30 138 41 24 10 36 57 81
2024/20251.442 36 29 123 70 125 52 52 106 186 130 287 246
2025/20263.751 454 105 418 412 612 173 615 218 283 243 141 77
Totale 9.124